(Q45227423)

English

Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase

scientific article published on 4 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

0 references

0 references

3C-like proteinase [SARS-Cov]

0 references

0 references

Lindsay D. Eltis

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

John Christopher Vederas

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

object named as

Carly Huitema

2

0 references

author name string

Jianmin Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Chunying Niu

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Jiang Yin

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Michael N G James

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Bioorganic Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

229-240

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms and enzymes involved in SARS coronavirus genome expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition and catalytic mechanism of HIV-1 aspartic protease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereoelectronic substituent effects in polyhydroxylated piperidines and hexahydropyridazines

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small molecules targeting severe acute respiratory syndrome human coronavirus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18295820

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BIOORG.2008.01.001

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45227423&oldid=2070690317"